Transplant oncology and anti-cancer immunosuppressants
Organ transplantation is a life-saving intervention that enhances the quality of life for patients with end-stage organ failure. However, long-term immunosuppressive therapy is required to prevent allogeneic graft rejection, which inadvertently elevates the risk of post-transplant malignancies, espe...
Saved in:
Main Authors: | Dejun Kong, Jinliang Duan, Shaofeng Chen, Zhenglu Wang, Jiashu Ren, Jianing Lu, Tao Chen, Zhuolun Song, Di Wu, Yuan Chang, Zhongqian Yin, Zhongyang Shen, Hong Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1520083/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ENDOPROSTHESIS OF THE SHOULDER JOINT IN METASTATIC LESIONS OF THE PROXIMAL HUMERUS DURING IMMUNOSUPPRESSIVE THERAPY
by: M. V. Ivanova, et al.
Published: (2017-03-01) -
Targeting TCMR-associated cytokine genes for drug screening identifies PPARγ agonists as novel immunomodulatory agents in transplantation
by: Lu Hu, et al.
Published: (2025-01-01) -
Immunosuppressive therapy and nutritional diseases of patients after kidney transplantation: a systematic review
by: Aleksandra Anna Kajdas, et al.
Published: (2025-01-01) -
The Evolution of Immunosuppressive Therapy in Pig-to-Nonhuman Primate Organ Transplantation
by: S. A. Sanatkar, et al.
Published: (2025-01-01) -
A novel cytoprotective organ perfusion platform for reconstructing homeostasis of DCD liver while alleviating IRI injury
by: Tingting Lan, et al.
Published: (2025-01-01)